![]() |
Home | Library | PRIME | Newsroom | A-Z Guide | E-mail | Directions | |
Pediatric PublicationsKohlhoff SA, Roblin PM, Reznik T, Hawser S, Islam K, Hammerschlag MR. In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae. Antimicrob Agents Chemother 48:1885-6, 2004. Kohlhoff S, Marciano T, Rawstron S. Low-dose acyclovir for HSV-2 meningitis in a child. Acta Paediatr 2004;93(8):1123-4. Kumar S, Hammerschlag MR. The accidental tourist: Globalization and food-borne disease outbreaks. Infect Med 21:149-51, 2004 Riska PF, Kutlin A, Ajiboye P, Cua A, Roblin PM, Hammerschlag MR. Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae. Antimicrob Agents Chemother 48:3586-3690, 2004. Alam M, Hammerschlag MR. SARS and emerging zoonoses. Infect Med 21:327-328, 2004. Kutlin A, Kohlhoff S, Roblin P, Hammerschlag MR, Riska P. Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis. Antimicrob Agents Chemother 49:903-907, 2005. Kumar S, Kohlhoff S, Gelling M, Roblin PM, Kutlin A, Kahane S, Friedman MG, Hammerschlag MR. Infection with Simkania negevensis in Brooklyn, New York. Pediatr Infect Dis J 24:989-992, 2005. Sleiman J, Hammerschlag, MR. ESBL-producing Gram-negative bacteria: A new threat to the community? Infect Med 23:0177-178, 2006. Kumar S, Kutlin S, Roblin P, Kohlhoff S, Bodetti T, Timms P, Hammerschlag MR. Isolation and antimicrobial susceptibilities of chlamydial isolates from western barred bandicoots. J Clin Microbiol, in press, 2006. |